Pharmacovigilance Risk Assessment Committee (PRAC): 25-29 September 2017

  • Email
  • Help

Details

TitlePharmacovigilance Risk Assessment Committee (PRAC): 25-29 September 2017
Date25/09/2017 - 29/09/2017
LocationEuropean Medicines Agency, London, UK
SummaryThe Pharmacovigilance Risk Assessment Committee (PRAC) is the committee that is responsible for assessing all aspects of the risk management of medicines for human use.

All documents

Media Videos


Related information

Public hearing

The PRAC will hold a public hearing on valproate and related substances on 26 September 2017.